{"id":2756,"date":"2017-06-14T15:25:00","date_gmt":"2017-06-14T19:25:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/"},"modified":"2018-02-06T17:01:17","modified_gmt":"2018-02-06T22:01:17","slug":"new-models-of-kidney-cancer-may-drive-immunotherapy-research","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/","title":{"rendered":"New models of kidney cancer may drive immunotherapy research"},"content":{"rendered":"

<\/p>\n

UNC Lineberger member and Associate Professor of Genetics, William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers.<\/p>\n

\n
\"\"
William Y. Kim, MD<\/figcaption><\/figure>\n<\/div>\n

June 8, 2017<\/p>\n

University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed preclinical laboratory models of the two most common types of kidney cancer, an advancement that may aid in the evaluation of novel immunotherapy combinations and targets.<\/p>\n

William Y. Kim, MD<\/a>, a UNC Lineberger member and associate professor in the UNC School of Medicine, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers. The researchers envision using the models to study new potential treatments, including possible immunotherapy approaches.<\/p>\n

\u201cHaving faithful genetic models of kidney cancer will enable us to develop a better understanding of the biology behind these cancers,\u201d said Kim. \u201cWe also can use these models to look for new targets and validate them in the preclinical setting more quickly as well as to test possible novel treatments that, if they work well, could be considered for patients with these genomic alterations.\u201d<\/p>\n

Kidney cancer is the eighth most commonly diagnosed cancer in the United States. The National Cancer Institute estimates 65,000 people will be diagnosed with kidney cancer in the U.S. this year, and it will account for 14,000 deaths. Approximately 70 percent of kidney cancer cases are clear cell renal cell carcinoma and 10 percent are papillary renal cell carcinoma.<\/p>\n

\u201cIf there are certain therapies that seem to work in these models, we can identify these same genetic abnormalities in people with these cancer types, since they may be the most likely to benefit,\u201d Kim said. \u201cThey will also be critical for testing new immunotherapy approaches, as these models have intact immune systems, which is something that has been limited in previous preclinical models of kidney cancer.\u201d<\/p>\n

Although several targeted treatments have been approved by the U.S. Food and Drug Administration for renal cell carcinoma, Kim said they target just two molecular pathways. Finding additional ways to attack kidney cancer using the models could be important for patients who have relapsed and are resistant to the existing treatments, he said.<\/p>\n

~the above is excerpted from an article on SOM News – read the full article here<\/a><\/p>\n

Read the online research article, “MYC activation cooperates with Vhl and Ink4a\/Arf loss to induce clear cell renal cell carcinoma” in Nature Communications here<\/a>.<\/em><\/p>\n

In addition to Kim, other UNC authors include: Sean T. Bailey, Aleisha M. Smith, Jordan Kardos, Sara E. Wobker, Harper L. Wilson, Bhavani Krishnan, Ryoichi Saito, Jing Zhang, Samuel C. Eaton, Lindsay A. Williams, Ujjawal Manocha, Qing Zhang, Joel S. Parker, Jen Jen Yeh, Richard A. Moffitt, and Janet Y. Leung.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"

UNC Lineberger member and Associate Professor of Genetics, William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers. June 8, 2017 University of North … Read more<\/a><\/p>\n","protected":false},"author":22429,"featured_media":2757,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"class_list":["post-2756","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","odd"],"acf":[],"yoast_head":"\nNew models of kidney cancer may drive immunotherapy research | Department of Genetics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New models of kidney cancer may drive immunotherapy research | Department of Genetics\" \/>\n<meta property=\"og:description\" content=\"UNC Lineberger member and Associate Professor of Genetics, William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers. June 8, 2017 University of North … Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Genetics\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-14T19:25:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-06T22:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"266\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Betsy Clarke\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Betsy Clarke\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\"},\"author\":{\"name\":\"Betsy Clarke\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/3e65c5e305af236859b9a4eb4a6e634d\"},\"headline\":\"New models of kidney cancer may drive immunotherapy research\",\"datePublished\":\"2017-06-14T19:25:00+00:00\",\"dateModified\":\"2018-02-06T22:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\"},\"wordCount\":510,\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\",\"name\":\"New models of kidney cancer may drive immunotherapy research | Department of Genetics\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg\",\"datePublished\":\"2017-06-14T19:25:00+00:00\",\"dateModified\":\"2018-02-06T22:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg\",\"width\":400,\"height\":266},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/genetics\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New models of kidney cancer may drive immunotherapy research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/\",\"name\":\"UNC Department of Genetics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/genetics\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#organization\",\"name\":\"UNC Department of Genetics\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2018\/11\/Genetics_logo_png_h.png\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2018\/11\/Genetics_logo_png_h.png\",\"width\":982,\"height\":151,\"caption\":\"UNC Department of Genetics\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/3e65c5e305af236859b9a4eb4a6e634d\",\"name\":\"Betsy Clarke\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25ba07221073ee574f6968de65b751ed2082edc9542330c40b955682b5eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25ba07221073ee574f6968de65b751ed2082edc9542330c40b955682b5eeb?s=96&d=mm&r=g\",\"caption\":\"Betsy Clarke\"},\"description\":\"Pharmacology\",\"url\":\"https:\/\/www.med.unc.edu\/genetics\/author\/bclarke\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New models of kidney cancer may drive immunotherapy research | Department of Genetics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/","og_locale":"en_US","og_type":"article","og_title":"New models of kidney cancer may drive immunotherapy research | Department of Genetics","og_description":"UNC Lineberger member and Associate Professor of Genetics, William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers. June 8, 2017 University of North … Read more","og_url":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/","og_site_name":"Department of Genetics","article_published_time":"2017-06-14T19:25:00+00:00","article_modified_time":"2018-02-06T22:01:17+00:00","og_image":[{"width":400,"height":266,"url":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","type":"image\/jpeg"}],"author":"Betsy Clarke","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Betsy Clarke","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/"},"author":{"name":"Betsy Clarke","@id":"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/3e65c5e305af236859b9a4eb4a6e634d"},"headline":"New models of kidney cancer may drive immunotherapy research","datePublished":"2017-06-14T19:25:00+00:00","dateModified":"2018-02-06T22:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/"},"wordCount":510,"publisher":{"@id":"https:\/\/www.med.unc.edu\/genetics\/#organization"},"image":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/","url":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/","name":"New models of kidney cancer may drive immunotherapy research | Department of Genetics","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/genetics\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","datePublished":"2017-06-14T19:25:00+00:00","dateModified":"2018-02-06T22:01:17+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#primaryimage","url":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","width":400,"height":266},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/genetics\/new-models-of-kidney-cancer-may-drive-immunotherapy-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/genetics\/"},{"@type":"ListItem","position":2,"name":"New models of kidney cancer may drive immunotherapy research"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/genetics\/#website","url":"https:\/\/www.med.unc.edu\/genetics\/","name":"UNC Department of Genetics","description":"","publisher":{"@id":"https:\/\/www.med.unc.edu\/genetics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/genetics\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.med.unc.edu\/genetics\/#organization","name":"UNC Department of Genetics","url":"https:\/\/www.med.unc.edu\/genetics\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/logo\/image\/","url":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2018\/11\/Genetics_logo_png_h.png","contentUrl":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2018\/11\/Genetics_logo_png_h.png","width":982,"height":151,"caption":"UNC Department of Genetics"},"image":{"@id":"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/3e65c5e305af236859b9a4eb4a6e634d","name":"Betsy Clarke","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/genetics\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2bb25ba07221073ee574f6968de65b751ed2082edc9542330c40b955682b5eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bb25ba07221073ee574f6968de65b751ed2082edc9542330c40b955682b5eeb?s=96&d=mm&r=g","caption":"Betsy Clarke"},"description":"Pharmacology","url":"https:\/\/www.med.unc.edu\/genetics\/author\/bclarke\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image-300x200.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/genetics\/wp-content\/uploads\/sites\/481\/2017\/10\/new-models-of-kidney-cancer-may-drive-immunotherapy-research-image-150x150.jpeg","featured_image_alt":"","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/genetics\/category\/news\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/posts\/2756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/users\/22429"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/comments?post=2756"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/posts\/2756\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/media\/2757"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/media?parent=2756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/categories?post=2756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/genetics\/wp-json\/wp\/v2\/tags?post=2756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}